A Different Method of Evaluation of the ERSPC Trial Confirms That Prostate-specific Antigen Testing Has a Significant Impact on Prostate Cancer Mortality-Reference-Cited by-同舟云学术

A Different Method of Evaluation of the ERSPC Trial Confirms That Prostate-specific Antigen Testing Has a Significant Impact on Prostate Cancer Mortality

Published:2014-09 Issue:3 Volume:66 Page:401-403
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Zappa Marco,Puliti Donella,Hugosson Jonas,Schröder Fritz H.,van Leeuwen Pim J.,Kranse Ries,Auvinen Anssi,Carlsson Sigrid,Kwiatkowski Maciej,Nelen Vera,Borda Alvaro Paez,Roobol Monique J.,Villers Arnauld

Publisher

Elsevier BV

Subject

Urology

Reference11 articles.

1. Prostate-cancer mortality at 11 years of follow-up;Schröder;N Engl J Med,2012

2. Screening and prostate-cancer mortality in a randomized European study;Schröder;N Engl J Med,2009

3. The excess mortality rate: a useful concept in cancer epidemiology;Lenner;Acta Oncol,1990

4. Low all-cause mortality in the volunteer-based Rotterdam section of the European Randomised Study of Screening for Prostate Cancer: self-selection bias?;Otto;J Med Screen,2004

5. Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendees;Bergdahl;Cancer,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of an imageless machine‐learning algorithm for the initial screening of prostate cancer;The Prostate;2024-04-04

2. Two New Modifications of the InterCriteria Analysis;Proceedings of the Bulgarian Academy of Sciences;2023-01-30

3. Intervention-related Deaths in the European Randomized Study of Screening for Prostate Cancer;European Urology Open Science;2021-12

4. Prostate Cancer;International Manual of Oncology Practice;2019

5. Peptide-Based Radiopharmaceuticals for Molecular Imaging of Prostate Cancer;Molecular & Diagnostic Imaging in Prostate Cancer;2018